Among the cancer susceptibility genes,
TP53
is one of the crucial genes involved in cell cycle regulations and, therefore, it greatly affects breast cancer initiation and progression. In addition,
WRAP53
—a natural antisense transcript—regulates
TP53
transcription and, as a protein, modulates the normal cell cycle, which results in breast cancer susceptibility. In this study, we aimed to analyze a haplotype comprising four SNPs, including rs1042522, rs17878362, rs2287499, and rs2287498, which are located at 5′ regions of the
TP53
and
WRAP53
genes, in 118 patients and 110 healthy controls of the Iranian-Azeri population.
In silico
studies were conducted using the SIFT, Polyphen2, Fanthmm, RNAsnp, and SNP&GO online servers. Linkage disequilibrium (LD) and D′ for each combination of the markers were calculated via the Haploview program. Our results showed that the GA
1
CC haplotype was the most frequent in the studied population. Additionally, no significant LD between any pairwise haplotypes was observed. The GA
1
CC and CA
2
GC haplotypes were significantly associated with breast cancer susceptibility. Moreover, the
in silico
analysis revealed the negative effects of rs2287499 and rs1042522 on
WRAP53
and P53, respectively. In conclusion, the CA
1
GC haplotype was strongly identified as a breast cancer risk factor, and the GA
1
CC haplotype was assumed to be a protective factor against breast cancer risk. Hence, these markers may potentially be used as molecular prognostic and predictive biomarkers for breast cancer.